ZA9711333B - In ovo vaccination against newcastle disease - Google Patents

In ovo vaccination against newcastle disease

Info

Publication number
ZA9711333B
ZA9711333B ZA9711333A ZA9711333A ZA9711333B ZA 9711333 B ZA9711333 B ZA 9711333B ZA 9711333 A ZA9711333 A ZA 9711333A ZA 9711333 A ZA9711333 A ZA 9711333A ZA 9711333 B ZA9711333 B ZA 9711333B
Authority
ZA
South Africa
Prior art keywords
newcastle disease
vaccination against
ovo vaccination
against newcastle
ovo
Prior art date
Application number
ZA9711333A
Other languages
English (en)
Inventor
Frans Gerrit Davelaar
Original Assignee
Dimminaco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag filed Critical Dimminaco Ag
Publication of ZA9711333B publication Critical patent/ZA9711333B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA9711333A 1996-12-17 1997-12-17 In ovo vaccination against newcastle disease ZA9711333B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96203572A EP0848956A1 (en) 1996-12-17 1996-12-17 In ovo vaccination against Newcastle Disease

Publications (1)

Publication Number Publication Date
ZA9711333B true ZA9711333B (en) 1999-06-17

Family

ID=8224711

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9711333A ZA9711333B (en) 1996-12-17 1997-12-17 In ovo vaccination against newcastle disease

Country Status (18)

Country Link
US (1) US6348197B1 (pt)
EP (2) EP0848956A1 (pt)
JP (1) JP2001506253A (pt)
KR (1) KR100540856B1 (pt)
CN (1) CN1146443C (pt)
AR (1) AR010794A1 (pt)
AT (1) ATE271883T1 (pt)
AU (1) AU5758798A (pt)
BR (1) BR9713582A (pt)
CA (1) CA2273074C (pt)
DE (1) DE69730040T2 (pt)
DK (1) DK0938335T3 (pt)
ES (1) ES2224294T3 (pt)
HK (1) HK1022273A1 (pt)
PT (1) PT938335E (pt)
TW (1) TW537896B (pt)
WO (1) WO1998026800A1 (pt)
ZA (1) ZA9711333B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2312626A1 (en) 1999-07-27 2001-01-27 Akzo Nobel N.V. A recombinant newcastle disease virus as an embryo vaccine
EP1074614B1 (en) * 1999-07-27 2004-07-07 Akzo Nobel N.V. A recombinant Newcastle disease virus for in ovo vaccination
AR031405A1 (es) 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
ATE307606T1 (de) 2001-10-04 2005-11-15 Ct Voor Onderzoek In Diergenee Abgeschwächter mutantenstamm eines virus der newcastle-krankheit für eine in ovo impfung und dessen benutzung
JP2006511450A (ja) * 2002-06-21 2006-04-06 ウェルスタット バイオロジクス コーポレーション 治療用ウイルスの投与
TW200502402A (en) * 2002-12-06 2005-01-16 Wyeth Corp Escape mutants of newcastle disease virus as marker vaccines
DE602004028736D1 (de) * 2003-06-20 2010-09-30 Microbix Biosystems Inc Verbesserungen bei der virusproduktion
JP5014413B2 (ja) * 2006-03-30 2012-08-29 エンブレックス・インコーポレイテッド 家禽のワクチン接種のための方法及び組成物
FR2921387B1 (fr) * 2007-09-26 2012-04-20 Sanofi Pasteur Procede de production du virus de la grippe
CN102559607B (zh) * 2012-01-04 2013-03-27 扬州大学 新城疫病毒高粘膜免疫水平弱毒疫苗株ndv/lx及反向遗传构建系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458630A (en) 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
ATE112490T1 (de) * 1988-07-18 1994-10-15 Duphar Int Res Lebende newcastle-krankheit-virus-vakzine.
US5427791A (en) 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease

Also Published As

Publication number Publication date
TW537896B (en) 2003-06-21
KR20000069501A (ko) 2000-11-25
DE69730040T2 (de) 2004-12-30
PT938335E (pt) 2004-11-30
US6348197B1 (en) 2002-02-19
KR100540856B1 (ko) 2006-01-12
CN1240360A (zh) 2000-01-05
ES2224294T3 (es) 2005-03-01
CA2273074A1 (en) 1998-06-25
EP0848956A1 (en) 1998-06-24
CA2273074C (en) 2008-04-29
WO1998026800A1 (en) 1998-06-25
EP0938335B1 (en) 2004-07-28
ATE271883T1 (de) 2004-08-15
DE69730040D1 (de) 2004-09-02
HK1022273A1 (en) 2000-08-04
CN1146443C (zh) 2004-04-21
EP0938335A1 (en) 1999-09-01
JP2001506253A (ja) 2001-05-15
AU5758798A (en) 1998-07-15
AR010794A1 (es) 2000-07-12
DK0938335T3 (da) 2004-11-29
BR9713582A (pt) 2000-04-04

Similar Documents

Publication Publication Date Title
IL118489A (en) In ovo vaccination against coccidiosis
GB9620795D0 (en) Vaccines
CY2568B1 (en) Acellular pertussis vaccine with diphtheriae- and tetanus- toxoids
EP0958373A4 (en) Vaccines.
IL118490A0 (en) In ovo vaccination against coccidiosis
ZA9711333B (en) In ovo vaccination against newcastle disease
ZA979592B (en) Oral vaccine for animals
GB9626864D0 (en) Vaccine
HUP9601608A2 (en) Marek`s disease vaccine
GB9625968D0 (en) Vaccine
GB9608106D0 (en) Animal Vaccines
GB9609252D0 (en) Vaccines
ZA964724B (en) In ovo vaccination against coccidiosis.
GB9622797D0 (en) Vaccine components against streptococcal disease
GB9625967D0 (en) Vaccine
GB9625966D0 (en) Vaccine
GB9606032D0 (en) Vaccines
GB9626882D0 (en) Vaccines
GB9614182D0 (en) Vaccines
GB9605229D0 (en) Vaccines
GB9604596D0 (en) Vaccines
GB9604595D0 (en) Vaccines
GB9602617D0 (en) Vaccines
GB9724112D0 (en) Warming pet cushion
PL106942U1 (en) Drinker for birds in particular for piegeons